Market Research Logo

Global Liquid Biopsy Market, Analysis and Forecast, 2017-2025 (Focus on Product Type, Therapeutic Application, End User, Market Share Analysis, Country Analysis, and Competitive Landscape)

Global Next Generation Sequencing (NGS) Market - Analysis and Forecast (2017-2024) (Focus on Product Type, Technology, Application, Country Analysis, Market Share Analysis, Funding Scenario, Trend Analysis, and Competitive Landscape)

The Next Generation Sequencing (NGS) Industry is a multibillion market which consists of multitudinous companies involved in the manufacturing of instruments, kits & consumables, and development of software to bolster the NGS workflow.

Advancements in sequencing chemistry, molecular biology, and technical engineering over the years have profoundly increased the sequencing efficiency while decreasing the cost. Impressive progress in these fields have paved the way for development of massively parallel, high-throughput sequencing technology, known as Next Generation Sequencing (NGS).

The purpose of this study is to gain a holistic view of the NGS market in terms of various influencing factors, such as recent trends, technological advancements, role of service providers, and funding scenario in the market. The scope of this report constitutes of an in-depth study of the global next generation sequencing market, including a thorough analysis of the products across different regions. The market has been segmented into ‘technology’, ‘product’, ‘application’ and ‘geographical regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global NGS market with the help of key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key ecosystem players and key strategies & developments taking place in this market. In addition, the report includes market dynamics (market drivers, opportunities and challenges) and industry analysis.

The research study considers the market share analysis for a comprehensive understanding of the global NGS market and assesses the factors governing the same. Funding scenarios, Porter’s five force analysis, opportunity matrix, detailed product mapping and R&D analysis have been included in the report.

The market by region has been further sub-segmented in countries and in each sub-segments, key market trends, list of key players, and recent developments were listed.

The answers to the following key questions can be derived from this report:

  • What are the major market drivers, challenges and opportunities in the global next generation sequencing market?
  • How did the next generation sequencing market evolve and what is its scope in the future?
  • What are the key developmental strategies which are being implemented by the key players to stand out in this market? Among these strategies which strategy is currently dominating the market?
  • What is the total addressable market (TAM), segmental addressable market (SAM) and the potential market opportunity of the global next generation sequencing market?
  • What is the market share of different leading segments and sub-segments of the market for the years 2017 and 2024?
  • How will each segment of the global next generation sequencing market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2024?
  • Who are the key players dominating the global next generation sequencing market and their respective share in the market?
  • Who are the key players dominating the next generation sequencing market, in different product segments namely instruments and kits & reagents?
  • What are the influencing factors that may affect the market share of the key players?
  • What is the perception of investors worldwide towards the market and which type of companies are receiving significant investments?
  • Who are the leading service providers of sequencing tests and what is their contribution to the market? What is the concentration of service providers worldwide?
  • How the market has been segmented on the basis of technology? Which technology is leading and and what is its share in the market?
  • Which geographical location will contribute to the highest sales of sequencing products and how regions have been further segmented into countries?
  • Who are the key players dominating the next generation sequencing market, in different regions namely North America, Europe, and Asia Pacific and their respective share?
  • What is the market share of companies by different segments, namely products, technology, and geography, along with the global share analysis of market?
  • What is the investors’ perception towards the market?
  • What is the frequency of service providers’ presence in different geographical regions?
The key players which have been contributing significantly to the NGS market include 10x Genomics, Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, GenapSys, Inc., Illumina, Inc., New England Biolabs, Inc., NuGEN Technologies Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Partek, Inc., PerkinElmer, Inc., QIAGEN, and Thermo Fisher Scientific, among others.


Executive Summary
1 Report Scope & Methodology
1.1 Scope of the Report
1.2 Market segmentation
1.3 Research Methodology
1.3.1 Data Triangulation
1.3.2 Key Data Points From Primary Sources
1.3.3 Key Data Points From Secondary Sources
1.3.4 Secondary Data Sources
1.3.5 Top-Down Approach (Segmental Analysis)
1.3.6 Bottom-Up Approach (Segmental Analysis)
1.4 Assumptions and Limitations
1.5 Data and Prediction Modelling
2 Market Overview
2.1 Introduction
2.2 Overview of Liquid Biopsy Techniques and Applications
2.3 Historical trends
2.4 Comparative Analysis of Tissue Biopsy and Liquid Biopsy
3 Market Dynamics
3.1 Promoting and Inhibiting Factors of Liquid Biopsy Market Growth
3.2 Drivers
3.3 Restraints
3.4 Opportunities
4 Competitive Insights
4.1 Share of Key Development and Strategies
4.2 Competitive Landscape
4.3 Market Share Analysis
4.4 Industry Attractiveness
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 Global Liquid Biopsy Market, by Product
5.1 Overview
5.2 Kits and Consumables
5.3 Instruments
5.4 Services
6 Global Liquid Biopsy Market, by Type of Biomarker
6.1 Overview
6.2 Circulating Tumor Cell (CTC)
6.3 Circulating Tumor DNA (ctDNA)
6.4 Extracellular Vesicles (EVs)
6.5 Other Types of Biomarkers
7 Global Liquid Biopsy Market, by Cancer Type
7.1 Liquid Biopsy's Role in Cancer Detection: An Overview
7.2 Liquid Biopsy: Role in Lung Cancer Diagnosis
7.3 Liquid Biopsy: Role in Breast Cancer Diagnosis
7.4 Liquid Biopsy: Role in Colorectal Cancer Diagnosis
7.5 Liquid Biopsy: Role in Prostate Cancer Diagnosis
7.6 Liquid Biopsy: Role in Liver Cancer Diagnosis
7.7 Liquid Biopsy: Role in Other Cancer Diagnosis
8 Global Liquid Biopsy Market, by End User
8.1 Overview
8.2 Reference Laboratories
8.3 Hospitals and Physician Laboratories
8.4 Academic and Research Centers
8.5 Other End Users
9 Global Liquid Biopsy Market, by Geography
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of the Asia Pacific
9.5 Rest of the World
10 Company Profile
10.1 Adaptive Biotechnologies
10.1.1 Overview
10.1.2 Adaptive Biotechnologies: Corporate Summary
10.1.3 Adaptive Biotechnologies: SWOT Analysis
10.2 ANGLE plc
10.2.1 Overview
10.2.2 Financials
10.2.2.1 Financial Summary
10.2.3 ANGLE plc: SWOT Analysis
10.3 Biocept, Inc.
10.3.1 Overview
10.3.2 Financials
10.3.2.1 Financial Summary
10.3.3 Biocept, Inc.: SWOT Analysis
10.4 Bio-Rad Laboratories, Inc.
10.4.1 Overview
10.4.2 Bio-Rad Laboratories, Inc.: Product Portfolio
10.4.3 Financials
10.4.3.1 Financial Summary
10.4.4 Bio-Rad Laboratories, Inc.: SWOT Analysis
10.5 CareDx, Inc.
10.5.1 Overview
10.5.2 Financials
10.5.2.1 Financial Summary
10.5.3 CareDx, Inc.: SWOT Analysis
10.6 Cynvenio Biosystems, Inc.
10.6.1 Overview
10.6.2 Cynvenio Biosystems, Inc.: Product Portfolio
10.6.3 Corporate Summary
10.6.4 Cynvenio Biosystems, Inc.: SWOT Analysis
10.7 Epic Sciences, Inc.
10.7.1 Overview
10.7.2 Epic Sciences, Inc.: Corporate Summary
10.7.3 Epic Sciences, Inc.: SWOT Analysis
10.8 F. Hoffmann-La Roche AG
10.8.1 Overview
10.8.2 F. Hoffmann-La Roche AG: Product Portfolio
10.8.3 Financials
10.8.3.1 Financial Summary
10.8.4 F. Hoffmann-La Roche AG: SWOT Analysis
10.9 Genomic Health, Inc.
10.9.1 Overview
10.9.2 Genomic Health, Inc.: Product Portfolio
10.9.3 Financials
10.9.3.1 Financial Summary
10.9.4 Genomic Health, Inc.: SWOT Analysis
10.10 GUARDANT HEALTH, INC
10.10.1 Overview
10.10.2 GUARDANT HEALTH, INC: Corporate Summary
10.10.3 GUARDANT HEALTH, INC: SWOT Analysis
10.11 Illumina, Inc.
10.11.1 Overview
10.11.2 Illumina, Inc.: Product Portfolio
10.11.3 Financials
10.11.3.1 Financial Summary
10.11.4 Illumina, Inc.: SWOT Analysis
10.12 JOHNSON & JOHNSON
10.12.1 Overview
10.12.2 JOHNSON & JOHNSON: Product Portfolio
10.12.3 Financials
10.12.3.1 Financial Summary
10.12.4 JOHNSON & JOHNSON: SWOT Analysis
10.13 MDxHealth, Inc.
10.13.1 Overview
10.13.2 Financials
10.13.2.1 Financial Summary
10.13.3 MDxHealth, Inc.: SWOT Analysis
10.14 Menarini Silicon Biosystems, Inc.
10.14.1 Overview
10.14.2 Menarini Silicon Biosystems, Inc.: Product Portfolio
10.14.3 Corporate Summary
10.14.4 Menarini Silicon Biosystems, Inc.: SWOT Analysis
10.15 Myriad Genetics, Inc.
10.15.1 Overview
10.15.2 Myriad Genetics, Inc.: Product Portfolio
10.15.3 Financials
10.15.3.1 Financial Summary
10.15.4 Myriad Genetics, Inc.: SWOT Analysis
10.16 Natera, Inc.
10.16.1 Overview
10.16.2 Natera, Inc.: Product Portfolio
10.16.3 Financials
10.16.3.1 Financial Summary
10.16.4 Natera, Inc.: SWOT Analysis
10.17 NeoGenomics Laboratories, Inc.
10.17.1 Overview
10.17.2 NeoGenomics Laboratories, Inc.: Product Portfolio
10.17.3 Financials
10.17.3.1 Financial Summary
10.17.4 NeoGenomics Laboratories, Inc.: SWOT Analysis
10.18 QIAGEN
10.18.1 Overview
10.18.2 QIAGEN: Product Portfolio
10.18.3 Financials
10.18.3.1 Financial Summary
10.18.4 QIAGEN: SWOT Analysis
10.19 RainDance Technologies, Inc.
10.19.1 Overview
10.19.2 RainDance Technologies, Inc.: Product Portfolio
10.19.3 Financials
10.19.3.1 Financial Summary
10.19.4 RainDance Technologies, Inc.: SWOT Analysis
10.20 Sysmex Corporation
10.20.1 Overview
10.20.2 Sysmex Corporation: Product Portfolio
10.20.3 Financials
10.20.3.1 Financial Summary
10.20.4 Sysmex Corporation: SWOT Analysis
10.21 Thermo Fisher Scientific
10.21.1 Overview
10.21.2 Thermo Fisher Scientific: Product Portfolio
10.21.3 Financials
10.21.3.1 Financial Summary
10.21.4 Thermo Fisher Scientific: SWOT Analysis
10.22 TROVAGENE, INC.
10.22.1 Overview
10.22.2 TROVAGENE, INC.: Product Portfolio
10.22.3 Financials
10.22.3.1 Financial Summary
10.22.4 TROVAGENE, INC.: SWOT Analysis
List of Tables
Cancer Incidence by Region, 2(Thousands)
Tissue Biopsy vs. Liquid Biopsy
Joint Ventures, Partnerships, Agreements and Collaborations
Product Launch
Mergers and Acquisitions
Regulatory Approval
Expansions and Others
List of Available Kits in the Market
List of Available Instruments and Platforms in the Market
List of Tests Available in the Market
Lung Cancer Incidence in Top Countries (2014-2025)
Breast Cancer Incidence in Top Countries (2014-2025)
Colorectal Cancer Incidence in Top Countries (2014-2025)
Prostate Cancer Incidence in Top Countries (2014-2025)
Liver Cancer Incidence in Top Countries (2014-2025)
Incidence Rate of Different Cancer Types, U.S. (2014-2025)
Incidence Rate of Different Cancer Types, Canada (2014-2025)
Incidence Rate of Different Cancer Types, U.K. (2014-2025)
Incidence Rate of Different Cancer Types, Germany (2014-2025)
Incidence Rate of Different Cancer Types, France (2014-2025)
Incidence Rate of Different Cancer Types, Italy (2014-2025)
Incidence Rate of Different Cancer Types, China (2014-2025)
Incidence Rate of Different Cancer Types, Japan (2014-2025)
Incidence Rate of Different Cancer Types, India (2014-2025)
Incidence Rate of Different Cancer Types, Australia (2014-2025)
Incidence Rate of Different Cancer Types, South Korea (2014-2025)
Incidence Rate of Different Cancer Types, Mexico (2014-2025)
Incidence Rate of Different Cancer Types, Turkey (2014-2025)
Incidence Rate of Different Cancer Types, Saudi Arabia (2014-2025)
Adaptive Biotechnologies: Overview
ANGLE plc: Overview
Biocept, Inc.: Overview
Bio-Rad Laboratories, Inc.: Overview
CareDx, Inc.: Overview
Cynvenio Biosystems, Inc.: Overview
Epic Sciences, Inc.: Overview
F. Hoffmann-La Roche AG: Overview
Genomic Health, Inc.: Overview
GUARDANT HEALTH, INC: Overview
Illumina, Inc.: Overview
JOHNSON & JOHNSON: Overview
MDxHealth, Inc.: Overview
Menarini Silicon Biosystems, Inc.: Overview
Myriad Genetics, Inc.: Overview
Natera, Inc.: Overview
NeoGenomics Laboratories, Inc.: Overview
QIAGEN: Overview
RainDance Technologies, Inc.: Overview
Sysmex Corporation: Overview
Thermo Fisher Scientific: Overview
TROVAGENE, INC.: Overview
List of Figures
Global Liquid Biopsy Market Revenue (2016-2025)
Global Liquid Biopsy Market Share, by Products and Services (2016)
Global Liquid Biopsy Market Share, by Products and Services (2025)
Global Liquid Biopsy Market Share, by Type of Biomarker (2016)
Global Liquid Biopsy Market Share, by Type of Biomarker (2025)
Global Liquid Biopsy Market Share, by Application (2016)
Global Liquid Biopsy Market Share, by Application (2025)
Global Liquid Biopsy Market Share, by End-User (2016)
Global Liquid Biopsy Market Share, by End-User (2025)
Liquid Biopsy Market Size, by Region
Liquid Biopsy Market Segmentation
Research Methodology
Evolution of Liquid Biopsy with Progress in Molecular Technologies and Biomarker Discovery
Comparative Analysis of Tissue Biopsy and Liquid Biopsy
Share of Key Development and Strategies
Market Share Analysis, by Companies (2015)
Market Share Analysis, by Companies (2016)
Porter’s Five Forces Analysis
Product Type Segmentation
Global Liquid Biopsy Market, by Product, 2016-2($Million)
Global Liquid Biopsy Market Share, by Product, 2016-2
Global Liquid Biopsy Kits & Consumables Market, 2016-2025
Global Liquid Biopsy Instruments Market, 2016-2($Million)
Global Liquid Biopsy Services Market, 2016-2($Million)
Different Biomarkers
Global Liquid Biopsy Market, by Biomarker Type, 2016-2($Million)
Global liquid Biopsy Market, by Circulating Tumor Cells (CTCs), 2016-2($Million)
List of Few CTC Based Kits and Instrument
Global liquid Biopsy Market, by Circulating Tumor DNA (ctDNA), 2016-2($Million)
List of Few ctDNA Based Kits and Instrument
CTCs Vs ctDNA Analysis
Global liquid Biopsy Market, by Extracellular Vesicles (EVs), 2016-2($Million)
Global liquid Biopsy Market, by Other Biomarkers (Cell Free DNA, etc.), 2016-2($Million)
Standard Biopsy Vs Liquid Biopsy
Types of Lung Cancer
Lung Cancer Incidence Rate Statistics
List of Few Kits and Instruments for Lung Cancer Diagnosis
Types of Breast cancer
Breast Cancer Incidence Statistics
List of Few Kits and Instruments for Breast Cancer Diagnosis
Infected Colon and Rectum
List of Few Kits and Instruments for Colorectal Cancer Diagnosis
Colorectal Cancer Incidence Statistics
Prostate Cancer Incidence Statistics
List of Few Kits and Instruments for Prostate Cancer Diagnosis
Types of Liver Cancer
Liver Cancer Incidence Statistics
Global Liquid Biopsy Market Share, by End Users, 2016-2025
Global Liquid Biopsy Market, by End Users, 2016-2($Million)
Global Liquid Biopsy End User Market, Reference Laboratories, 2016-2($Million)
Global Liquid Biopsy End User Market, Hospitals and Physician Laboratories, 2016-2($Million)
Global Liquid Biopsy End User Market, Academic and Research Centers, 2016-2($Million)
Global Liquid Biopsy End User Market, Others, 2016-2($Million)
Global Liquid Biopsy Market, by Region
Global Liquid Biopsy Market Revenue, by Region (2016-2025)
Global Liquid Biopsy Market Share, by Region (2016)
Global Liquid Biopsy Market Share, by Region (2025)
North America Liquid Biopsy Market Revenue (2016-2025)
North America Liquid Biopsy Market, by Products & Services (2016-2025)
North America Liquid Biopsy Market, by Country (2016-2025)
U.S. Liquid Biopsy Market Revenue (2016-2025)
Canada Liquid Biopsy Market Revenue (2016-2025)
Europe Liquid Biopsy Market Revenue (2016-2025)
Europe Liquid Biopsy Market, by Products & Services (2016-2025)
Europe Liquid Biopsy Market, by Country (2016-2025)
U.K. Liquid Biopsy Market Revenue (2016-2025)
Germany Liquid Biopsy Market Revenue (2016-2025)
France Liquid Biopsy Market Revenue (2016-2025)
Rest of Europe Liquid Biopsy Market Revenue (2016-2025)
Asia Pacific Liquid Biopsy Market Revenue (2016-2025)
Asia Pacific Liquid Biopsy Market, by Products & Services (2016-2025)
Asia Pacific Liquid Biopsy Market, by Country (2016-2025)
China Liquid Biopsy Market Revenue (2016-2025)
Japan Liquid Biopsy Market Revenue (2016-2025)
India Liquid Biopsy Market Revenue (2016-2025)
Rest of Asia Pacific Liquid Biopsy Market Revenue (2016-2025)
Rest of the World (RoW) Liquid Biopsy Market Revenue (2016-2025)
Adaptive Biotechnologies: SWOT Analysis
ANGLE plc: Overall Financials (2014-2016)
ANGLE plc: Revenue by Region
ANGLE plc: SWOT Analysis
Biocept, Inc.: Overall Financials (2014-2016)
Biocept, Inc.: SWOT Analysis
Bio-Rad Laboratories, Inc.: Product Mapping
Bio-Rad Laboratories, Inc.: Overall Financials (2014-2016)
Bio-Rad Laboratories, Inc.: Net Revenue by Business Segment (2014-2016)
Bio-Rad Laboratories, Inc.: Revenue by Region (2014-2016)
Bio-Rad Laboratories, Inc.: SWOT Analysis
CareDx: Overall Financials (2014-2016)
CareDx, Inc.: SWOT Analysis
Cynvenio Biosystems, Inc.: Product Mapping
Cynvenio Biosystems, Inc.: SWOT Analysis
Epic Sciences, Inc.: SWOT Analysis
F. Hoffmann-La Roche AG: Product Mapping
F. Hoffmann-La Roche AG: Overall Financials (2014-2016)
F. Hoffmann-La Roche AG: Revenue By Geographical Area (2014-2016)
F. Hoffmann-La Roche AG: Revenue by Division (2014-2016)
F. Hoffmann-La Roche AG: Revenue By Diagnostics Sub-Division (2014-2016)
F. Hoffmann-La Roche AG: SWOT Analysis
Genomic Health, Inc.: Product Mapping
Genomic Health, Inc.: Overall Financials (2014-2016)
Genomic Health, Inc.: Net Revenue by Region (2014-2016)
Genomic Health, Inc.: SWOT Analysis
GUARDANT HEALTH, INC: SWOT Analysis
Illumina, Inc: Product Mapping
Illumina, Inc.: Overall Financials (2014-2016)
Illumina, Inc.: Net Revenue by Business Segment (2014-2016)
Illumina, Inc.: Revenue by Region (2014-2016)
Illumina, Inc.: SWOT Analysis
JOHNSON & JOHNSON: Product Mapping
JOHNSON & JOHNSON: Overall Financials (2014-2016)
JOHNSON & JOHNSON: Net Revenue by Business Segment (2014-2016)
JOHNSON & JOHNSON: Net Revenue by Region (2014-2016)
JOHNSON & JOHNSON: Net Revenue by Medical Devices Business Segment (2014-2016)
JOHNSON & JOHNSON: SWOT Analysis
MDxHealth, Inc.: Overall Financials (2014-2016)
MDxHealth, Inc.: SWOT Analysis
Menarini Silicon Biosystems, Inc.: Product Mapping
Menarini Silicon Biosystems, Inc.: SWOT Analysis
Myriad Genetics, Inc.: Product Mapping
Myriad Genetics, Inc.: Overall Financials (2014-2016)
Myriad Genetics, Inc.: Net Revenue by Business Segment (2014-2016)
Myriad Genetics, Inc.: SWOT Analysis
Natera, Inc.: Product Mapping
Natera, Inc.: Overall Financials (2014-2016)
Natera, Inc.: Net Revenue by Region (2014-2016)
Natera, Inc.: SWOT Analysis
NeoGenomics Laboratories, Inc.: Product Mapping
NeoGenomics Laboratories, Inc.: Overall Financials (2014-2016)
NeoGenomics Laboratories, Inc.: Net Revenue by Business Segment (2014-2016)
NeoGenomics Laboratories, Inc.: SWOT Analysis
QIAGEN: Product Mapping
QIAGEN: Overall Financials (2014-2016)
QIAGEN: Net Revenue by Region (2014-2016)
Qiagen: Revenue by Business Segments (2014-2016)
QIAGEN: SWOT Analysis
RainDance Technologies, Inc.: Product Mapping
RainDance Technologies, Inc.: Overall Financials (2014)
RainDance Technologies: Net Revenue by Region (2014)
RainDance Technologies, Inc.: SWOT Analysis
Sysmex Corporation: Product Mapping
Sysmex Corporation: Overall Financials (2014- 2016)
Sysmex Corporation: Revenue by Business Segment (2014-2016)
Sysmex Corporation: Revenue by Region(2014-2016)
Sysmex Corporation: SWOT Analysis
Thermo Fisher Scientific: Product Mapping
Thermo Fisher Scientific: Overall Financials (2014-2016)
Thermo Fisher Scientific: Net Revenue by Business Segment (2014-2016)
Thermo Fisher Scientific: Net Revenue by Region (2014-2016)
Thermo Fisher Scientific: SWOT Analysis
TROVAGENE, INC.: Product Mapping
TROVAGENE, INC.: Overall Financials (2014-2016)
TROVAGENE, INC.: SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report